Press Release

United Kingdom Next Generation Sequencing Market to be dominated by Consumables till 2027

Continuous technological advancements in next generation sequencing in developed countries like United Kingdom is anticipated to cater to the growth of United Kingdom next generation sequencing market in the forecast period, 2023-2027.  

According to TechSci Research report,
United Kingdom Next Generation Sequencing Market - By Region, Competition Forecast & Opportunities, 2027, the United Kingdom next generation sequencing market is expected to witness steady growth in 2023-2027. Next-generation sequencing, also referred as high-throughput sequencing, represent the process of determining the sequence of nucleotides in a section of the DNA. It includes numerous procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing. NGS is a cost-effective solution that provide precise results with high accuracy and speed. This allows the analysis of millions of DNA molecules simultaneously, which facilitates research in personalized and genetic medicines, agriculture and animal research, and clinical diagnostics. Moreover, the escalating demand for early detection of cancer and infectious diseases drives the growth of the NGS market. Also, the growing use of NGS technology in clinical diagnosis, speed, cost, and accuracy of this sequencing method are supporting the growth of the market. Additionally, the increasing efficiency in replacing the traditional technologies (such as microarrays) and the expanding drug discovery applications demanding NGS technology propels the market growth. Various key market players are playing a vital role in the development of drugs with the help of NGS technology which is expected to augment the market growth over the forecast years.

However, absence of skilled professionals, and ethical and legal limitation associated with next genome sequencing are expected to restrict the market growth during the forecast period.

Browse over XX market data Figures spread through

The United Kingdom next generation sequencing market is segmented into product, technology, application, end user, regional distribution, and competitive landscape.

Based on product, the market is divided into consumables, platforms, services
. Consumables segment account for a large share in the market in the forecast period, 2023-2027. Consumables offers short durability, thereby there is a high replacement rate that escalates the demand for consumables. Also, consumables are ordered in abundant quantity from numerous producers owing to a cost-effective way for researchers as well as scientists that improves the market value. Major industry manufacturers are taking several efforts in developing innovative consumables that will help researchers gain accurate results, accelerating the industry expansion.

Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, single molecule real time sequencing, others. Sequencing by synthesis is expected to dominate during the forecast years, 2023-2027. The high accuracy of SBS technology in DNA sequencing, greatest yield of error free throughput, and rising incorporation of this technology in NGS instrumentation is driving the segmental growth.

Based on application, the market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, others
. Biomarkers and cancer segment is projected to hold the greatest share during the upcoming years, 2023-2027. It is due to the rise in prevalence of cancer and advancement in technology in next generation sequencing which propels the segmental growth.

Based on end user, the market is segmented into academic & clinical research centers, pharmaceutical & biotechnology companies, hospitals & clinics, others. Academic & clinical research centers is projected to augment the market growth during the forecast years, 2023-2027. The growing application-based utilization in these institutes and rising oncology research activities are fueling the growth of this segment.

Leading market players operating in the United Kingdom next generation sequencing market are:

  • Thermo Fischer Scientific, Inc.
  • Illumina Cambridge Limited
  • PerkinElmer (UK) Limited
  • Agilent Technologies UK Limited
  • Qiagen Manchester Limited
  • Oxford Nanopore Technologies Limited
  • Roche Diagnostics Limited


Customers can also request for 10% free customization on this report.

The growing prevalence of several medical diseases, including cancer, coupled with the numerous technological advancements in the field of medical sciences, is primarily supporting the growth of the next generation sequencing market. The expanding adoption of liquid biopsies in cancer diagnostics, has further escalated the utilization of NGS technologies which is propelling the market growth. These technologies use cell-free circulating tumor DNA (ctDNA) as a non-invasive cancer biomarker for real-time cancer monitoring and detection. In addition to this, the rising adoption of genome mapping programs to predict the development of several disorders is also providing an impetus to the market growth. Genetic maps are widely utilized for guiding scientists to analyse the genes that are responsible for increasing the prevalence of diabetes, heart diseases, asthma, cancer and psychiatric conditions. Furthermore, continuous technological advancements and integration with the cloud-computing systems for enhanced data management, are offering lucrative opportunities to the market players. The lowering costs of NGS systems and extensive research and development (R&D) activities in the area of sequencing chemistry, molecular biology and technical engineering, are expected to fuel the growth of United Kingdom next-generation sequencing market till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm”.


United Kingdom Next Generation Sequencing Market By Product (Consumables, Platforms, Services), By Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Single Molecule Real Time Sequencing, Others), By Application (Biomarkers & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Agriculture & Animal Research, Others), By End User (Academic & Clinical Research Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others), By Region, Competition Forecast & Opportunities, 2027 has analyzed the future growth potential of United Kingdom next generation sequencing  market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and assist decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with significant drivers, challenges, and opportunities in United Kingdom next generation sequencing market.

Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]

Relevant News